Dexamethasone Dosing for Metastatic Disease
Dosing Based on Symptom Severity
- For patients with metastatic disease and mild to moderate symptoms, the American Academy of Neurology recommends dexamethasone dosing at 4-8 mg/day 1, 2
- For patients with metastatic disease and moderate to severe symptoms with significant mass effect, the American Academy of Neurology recommends dexamethasone dosing at 16 mg/day or more 1, 3
Administration Considerations
- The American Academy of Neurology suggests that dexamethasone can be administered orally or intravenously with equivalent dosing 1, 2
- For single daily dosing, morning administration is preferred to minimize sleep disturbances, as recommended by the American Academy of Neurology 2
Choice of Corticosteroid
- Dexamethasone is the preferred corticosteroid for treating metastatic disease due to its relative lack of mineralocorticoid activity, according to the American Academy of Neurology 1, 2
Monitoring and Side Effects
- Common side effects of dexamethasone include hyperglycemia, sleep disturbances, increased risk of infection, and gastrointestinal complications, as reported by the American Academy of Neurology 2
- Long-term use of dexamethasone (>3 weeks) is associated with significant toxicity, including personality changes, suppressed immunity, metabolic derangements, and impaired wound healing, as warned by the American Academy of Neurology 2
Special Considerations
- Caution is advised when using corticosteroids in patients receiving immunotherapy, as systematic corticosteroids may attenuate the benefit of these treatments, according to the American Society of Clinical Oncology 4
- For patients receiving chemotherapy with moderate emetic risk, the American Society of Clinical Oncology recommends dexamethasone at 8 mg oral or IV as an antiemetic 5, 6
- For patients receiving highly emetic chemotherapy, the American Society of Clinical Oncology suggests adjusting dexamethasone dosing to 12 mg on day 1 when used with NK1 receptor antagonists 6